IQSI - ETF AI Analysis

Top Page

IQ Candriam ESG International Equity ETF (IQSI)

Rating:67Neutral

Price Target:―

The IQ Candriam ESG International Equity ETF (IQSI) has a solid overall rating, reflecting its strong holdings in companies like Novartis AG and Toyota. Novartis contributes positively with its robust profitability, stable balance sheet, and growth in key products, while Toyota adds strength through its strategic focus on electrification and attractive valuation metrics. However, weaker holdings like SAP SE and Commonwealth Bank of Australia, which face bearish momentum and valuation concerns, slightly temper the fund’s overall rating. The main risk factor is the ETF's exposure to diverse sectors, which may lead to mixed performance across holdings.

Positive Factors

Strong Top Holdings

Several top positions, such as ASML Holding and Sony, have shown strong year-to-date performance, contributing positively to the ETF's returns.

Global Diversification

The ETF is geographically diversified, with exposure to major economies like Japan, the UK, and Switzerland, reducing reliance on any single market.

Low Expense Ratio

The fund's expense ratio is low compared to many ETFs, making it cost-efficient for investors.

Negative Factors

Underperforming Holdings

Some key holdings, such as SAP and Toyota Motor, have lagged in performance, potentially dragging down overall returns.

Sector Concentration in Financials

The ETF has significant exposure to the financial sector, which could increase vulnerability to sector-specific risks.

Limited U.S. Exposure

With only 3.39% of assets in U.S. companies, the fund may miss out on opportunities in the world's largest economy.

IQSI vs. SPDR S&P 500 ETF (SPY)

AUM213.90M

RegionDeveloped Markets

Expense Ratio0.15%

Beta0.72

IssuerNew York Life Investments

Inception DateDec 17, 2019

Dividend Yield2.44%

Asset ClassEquity

Index TrackedIQ Candriam ESG International Equity Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume5,100

30 Day Avg. Volume11,904

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

38.33

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering568

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

IQSI Summary

The IQ Candriam ESG International Equity ETF (IQSI) is an investment fund that focuses on international companies meeting high environmental, social, and governance (ESG) standards. It tracks the IQ Candriam ESG International Equity Index, offering exposure to a wide range of industries and countries, including Japan, the UK, and Switzerland. Some of its top holdings include well-known companies like Nestlé and Toyota. Investors might consider IQSI for diversification and to align their investments with sustainable values. However, since it invests in global markets, its performance can be affected by international economic and political changes.

How much will it cost me?The IQ Candriam ESG International Equity ETF (IQSI) has an expense ratio of 0.15%, which means you’ll pay $1.50 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking an index rather than relying on active management.

What would affect this ETF?The IQ Candriam ESG International Equity ETF could benefit from growing global interest in ESG investing, as more individuals and institutions prioritize sustainability and ethical practices. However, its exposure to developed markets and sectors like Financials and Industrials may face challenges if economic growth slows or interest rates rise, which could impact corporate profitability. Additionally, regulatory changes or geopolitical tensions in key regions could create uncertainty for some of its top holdings.

IQSI Top 10 Holdings

The IQ Candriam ESG International Equity ETF leans heavily into developed markets, with a notable focus on health care and technology. Roche and AstraZeneca are steady performers, buoyed by strong pipelines and strategic growth, while ASML’s mixed momentum reflects its high valuation despite robust fundamentals. On the tech side, SAP is lagging, pulling down the fund’s overall performance with bearish signals. Meanwhile, Nestlé offers stability in consumer defensive, though recent dips hint at challenges. The fund’s diverse sector exposure balances rising stars with a few underperformers, creating a nuanced growth story.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	3.36%	$7.12M	€363.50B	43.06%	76 Outperform
AZN	AstraZeneca	2.14%	$4.53M	£210.71B	27.58%	80 Outperform
ROG	Roche Holding AG	2.14%	$4.53M	CHF248.72B	32.86%	73 Outperform
SAP	SAP SE	2.01%	$4.25M	€249.47B	-11.41%	66 Neutral
NOVN	Novartis AG	1.99%	$4.21M	CHF203.80B	19.23%	80 Outperform
NESN	Nestlé SA	1.98%	$4.20M	CHF199.21B	14.95%	71 Outperform
7203	Toyota Motor	1.62%	$3.43M	¥39.52T	15.33%	80 Outperform
SIE	Siemens	1.58%	$3.35M	€182.84B	20.82%	74 Outperform
CBA	Commonwealth Bank of Australia	1.34%	$2.85M	AU$257.81B	-1.81%	64 Neutral
6758	Sony	1.32%	$2.80M	¥26.47T	31.77%	73 Outperform

IQSI Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

34.41

Positive

100DMA

33.91

Positive

200DMA

32.50

Positive

Market Momentum

MACD

0.10

Negative

RSI

57.97

Neutral

STOCH

91.13

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IQSI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 34.36, equal to the 50-day MA of 34.41, and equal to the 200-day MA of 32.50, indicating a bullish trend. The MACD of 0.10 indicates Negative momentum. The RSI at 57.97 is Neutral, neither overbought nor oversold. The STOCH value of 91.13 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IQSI.

IQSI Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
IQSI	―	―	$213.90M	0.15%	―
URTH	―	―	$6.60B	0.24%	―
GLOV	―	―	$1.53B	0.25%	―
WSML	―	―	$773.19M	0.30%	―
GDIV	―	―	$218.07M	0.50%	―
QWLD	―	―	$174.68M	0.30%	―

Performance Comparison

IQSI

IQ Candriam ESG International Equity ETF

34.80

5.57

19.06%

URTH

iShares MSCI World ETF

―

GLOV

Goldman Sachs ActiveBeta World Low Vol Plus Equity ETF

―

WSML

iShares MSCI World Small-Cap ETF

―

GDIV

Harbor Dividend Growth Leaders ETF

―

QWLD

SPDR MSCI World StrategicFactors ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents